Back
Revance Therapeutics Quote, Financials, Valuation and Earnings
Sponsored
RVNC
Sponsored
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
13
RVNC
Revance Therapeutics
Last Price:
$3.09
Seasonality Move:
-2.77%
7 Day Trial
ALL ACCESS PASS
$
7
These 7 Stocks Will Be Magnificent in 2025
Get Your Copy of "These 7 Stocks Will Be Magnificent in 2025" Here.Revance Therapeutics Price Quote
$3.09
+0.01 (+0.65%)
(Updated: December 21, 2024 at 5:45 AM ET)
Revance Therapeutics Key Stats
Sell
13
Revance Therapeutics (RVNC)
is a Sell
Day range:
$3.07 - $3.09
52-week range:
$2.30 - $9.75
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.16
P/B ratio:
0%
Volume:
3.5M
Avg. volume:
3.6M
1-year change:
-59.37%
Market cap:
$323.1M
Revenue:
$234M
EPS:
$-1.94
How Much Does Revance Therapeutics Make?
Data Unavailable
Is Revance Therapeutics Growing As A Company?
Data Unavailable
Revance Therapeutics Stock Price Performance
-
Did Revance Therapeutics Stock Go Up Last Month?Revance Therapeutics share price went down by -18.95% last month
-
Did RVNC's Share Price Rise Over The Last Year?RVNC share price fell by -59.37% over the past 1 year
What Is Revance Therapeutics 52-Week High & Low?
-
What Is Revance Therapeutics’s 52-Week High Share Price?Revance Therapeutics has traded as high as $9.75 over the past 52 weeks
-
What Is Revance Therapeutics’s 52-Week Low Share Price?Revance Therapeutics has traded as low as $2.30 over the past 52 weeks
Revance Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Revance Therapeutics?
Data Unavailable
Is Revance Therapeutics Cash Flow Positive?
Data Unavailable
Revance Therapeutics Return On Invested Capital
Data Unavailable
Revance Therapeutics Earnings Date & Stock Price
-
What Is Revance Therapeutics's Stock Price Today?A single share of RVNC can be purchased today for 3.08
-
What Is Revance Therapeutics’s Stock Symbol?Revance Therapeutics trades on the nasdaq under the ticker symbol: RVNC
-
When Is Revance Therapeutics’s Next Earnings Date?The next quarterly earnings date for Revance Therapeutics is scheduled on February 28, 2025
-
When Is RVNC's next ex-dividend date?Revance Therapeutics's next ex-dividend date is May 15, 2020
-
How To Buy Revance Therapeutics Stock?You can buy Revance Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Revance Therapeutics Competitors
-
Who Are Revance Therapeutics's Competitors?Below is a list of companies who compete with Revance Therapeutics or are related in some way:
Revance Therapeutics Dividend Yield
Data Unavailable
Revance Therapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 6.33% |
Revenue: | 10.66% | -12.17% |
Analyst Recommendations
Buy Recommendations: | 1 |
---|---|
Hold Recommendations: | 7 |
Sell Recommendations: | 0 |
Price Target: | 7.64 |
Upside from Last Price: | 147.96% |
Major Shareholders
Data Unavailable